Cetera Trust Company N.A Makes New Investment in Shockwave Medical, Inc. (NASDAQ:SWAV)

Cetera Trust Company N.A bought a new position in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) during the 4th quarter, HoldingsChannel reports. The firm bought 800 shares of the company’s stock, valued at approximately $152,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Handelsbanken Fonder AB grew its holdings in Shockwave Medical by 10.9% during the 4th quarter. Handelsbanken Fonder AB now owns 7,100 shares of the company’s stock worth $1,353,000 after acquiring an additional 700 shares in the last quarter. Robbins Farley lifted its position in shares of Shockwave Medical by 1.0% during the fourth quarter. Robbins Farley now owns 4,542 shares of the company’s stock valued at $866,000 after buying an additional 45 shares during the last quarter. Federated Hermes Inc. lifted its position in shares of Shockwave Medical by 8.8% during the fourth quarter. Federated Hermes Inc. now owns 4,479 shares of the company’s stock valued at $854,000 after buying an additional 364 shares during the last quarter. HealthInvest Partners AB purchased a new stake in shares of Shockwave Medical during the fourth quarter valued at about $673,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Shockwave Medical by 12.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,133 shares of the company’s stock valued at $1,550,000 after buying an additional 917 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have commented on the stock. CL King reissued a “neutral” rating on shares of Shockwave Medical in a research report on Monday, April 8th. Morgan Stanley reissued an “equal weight” rating and set a $335.00 price target (up from $285.00) on shares of Shockwave Medical in a research report on Monday, April 8th. SVB Leerink reissued a “market perform” rating and set a $335.00 price target (down from $361.00) on shares of Shockwave Medical in a research report on Monday, April 8th. Wolfe Research reissued a “peer perform” rating on shares of Shockwave Medical in a research report on Friday, April 5th. Finally, Canaccord Genuity Group reissued a “hold” rating and set a $335.00 price target (up from $263.00) on shares of Shockwave Medical in a research report on Friday, April 5th. Ten equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $309.11.

Insiders Place Their Bets

In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total transaction of $450,000.00. Following the completion of the transaction, the director now directly owns 3,551 shares of the company’s stock, valued at approximately $1,065,300. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total transaction of $450,000.00. Following the completion of the transaction, the director now directly owns 3,551 shares of the company’s stock, valued at approximately $1,065,300. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Isaac Zacharias sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the transaction, the insider now directly owns 56,818 shares of the company’s stock, valued at $16,344,834.06. The disclosure for this sale can be found here. In the last ninety days, insiders sold 93,813 shares of company stock valued at $23,762,679. 3.40% of the stock is owned by insiders.

Shockwave Medical Stock Performance

Shares of Shockwave Medical stock opened at $328.60 on Tuesday. The firm has a market capitalization of $12.29 billion, a P/E ratio of 84.91, a PEG ratio of 2.44 and a beta of 0.92. The company has a quick ratio of 10.73, a current ratio of 11.76 and a debt-to-equity ratio of 1.09. The company has a 50 day moving average price of $287.78 and a 200 day moving average price of $230.12. Shockwave Medical, Inc. has a 52 week low of $157.00 and a 52 week high of $331.58.

Shockwave Medical (NASDAQ:SWAV) last announced its quarterly earnings data on Thursday, February 15th. The company reported $1.16 EPS for the quarter, beating the consensus estimate of $0.92 by $0.24. The firm had revenue of $202.98 million during the quarter, compared to analyst estimates of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. Shockwave Medical’s revenue was up 41.0% on a year-over-year basis. During the same period last year, the firm posted $3.71 EPS. Sell-side analysts expect that Shockwave Medical, Inc. will post 4.94 EPS for the current year.

Shockwave Medical Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.